addiction

How the WHO hepatitis strategy measures up in the field

According to the World Health Organization (WHO), approximately 296 million people globally live with hepatitis B, with most unaware of their infection. Africa is the worst impacted region for hepatitis B with a prevalence of 7.5 percent compared to 0.5 percent in the Americas. Hepatitis C impacts an estimated 58 million people across the globe. …

How the WHO hepatitis strategy measures up in the field Read More »

After Marijuana Legalization Did Opioid Overdoses Go Up, Stay the Same, or Go Down?

What happened in states after medical marijuana laws were passed? Did opioid overdoses go up, stay the same, or go down? Millions of people in the United States have been diagnosed with an opioid use disorder, and more than 80 Americans die each day from opioid overdose. Where is this coming from? Most “new heroin …

After Marijuana Legalization Did Opioid Overdoses Go Up, Stay the Same, or Go Down? Read More »

Marijuana Can be Habit-Forming

The evidence clearly indicates that long-term marijuana use can lead to addiction, but are there negative consequences? Evidently, “the evidence clearly indicates that long-term marijuana use can lead to addiction. Indeed, approximately 9% of those who experiment with marijuana will become addicted…The number goes up to about 1 in 6 among those who start using …

Marijuana Can be Habit-Forming Read More »

Understanding the Link Between Alcohol and Depression

Alcohol abuse is closely correlated with depression. This doesn’t necessarily mean one causes the other, but many people who suffer from depressive disorders turn to alcohol to escape.  On the other side of that coin, those who abuse or overuse alcohol can develop symptoms of depression or exacerbate symptoms that are already present. So, how …

Understanding the Link Between Alcohol and Depression Read More »

VC fund dedicated to psychedelic meds launches in UK

In the last few years, biopharma companies focusing on psychedelic medicines have been springing up like mushrooms – magic or otherwise – and venture capital money is starting to follow. Today sees the launch of the first investment fund in the UK devoted to psychedelic healthcare, with plans to invest in “revolutionary mind-altering medicines to …

VC fund dedicated to psychedelic meds launches in UK Read More »

Purdue to pay $8.3bn after admitting criminal charges in opioid case

After years of legal wrangling, Purdue Pharma has agreed a deal to resolve litigation about its role in the US opioid epidemic that will cost it up to $8.3 billion. As part of the criminal and civil settlement, the manufacturer of opioid painkiller OxyContin (oxycodone) pleaded guilty to a three-count felony, including two counts of …

Purdue to pay $8.3bn after admitting criminal charges in opioid case Read More »

After final $600M opioid settlement, Indivior looks to the future

UK drugmaker Indivior looks finally to have put years of uncertainty over its exposure to opioid litigation in the US behind it, after agreeing a $600 million settlement. The deal resolves criminal and civil liabilities faced by the company related to charges it engaged in an illicit nationwide scheme to increase prescriptions of opioid addiction …

After final $600M opioid settlement, Indivior looks to the future Read More »